<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00287690</url>
  </required_header>
  <id_info>
    <org_study_id>98-170</org_study_id>
    <nct_id>NCT00287690</nct_id>
  </id_info>
  <brief_title>Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease</brief_title>
  <official_title>The Effect of Genistein (Supro®) on Coronary Artery Diameter and Blood Flow in Men and Women With Coronary Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of genistein administration on coronary
      arteries in humans. We will measure the size of a coronary artery and the speed and amount of
      blood flow in response after subjects have ingested Supro® drinks (a soy protein drink
      containing genistein).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1999</start_date>
  <completion_date>April 2003</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary artery diameter</measure>
    <time_frame>On the day of angiography (day 3-4 after Supro/placebo started). No further follow-up.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coronary blood flow</measure>
    <time_frame>On the day of angiography (day 3-4 after Supro/placebo started). No further follow-up.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Genistein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supro drink once daily for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drink identical to Supro but containing no genistein, once daily for 3 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Genistein</intervention_name>
    <description>Drink taken once daily</description>
    <arm_group_label>Genistein</arm_group_label>
    <other_name>Supro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Drink taken once daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 30-75 years

          -  Patients requiring diagnostic coronary angiography

          -  Presence of coronary artery disease on angiogram but with at least one non-obstructed
             (lesions &lt;70% narrowed compared with the adjacent normal part of the vessel)
             atheromatous vessel (confirmed at diagnostic cardiac catheterisation)

          -  Female patients must be postmenopausal (FSH&gt;40 IU/L)

          -  Willing to give informed, written consent

        Exclusion Criteria:

          -  Age &lt;30 or &gt;75 years

          -  Allergy to radiographic contrast media

          -  Sino-atrial disease or significant bradycardia

          -  Concomitant medication with persantin (dipyridamole) or theophyllines

          -  Asthma

          -  Hypertension

          -  Left ventricular hypertrophy or dysfunction (clinical/ECG/echo/CXR)

          -  Female patients with FSH&lt;40 IU/L (postmenopausal)

          -  Female patients currently taking hormone therapy, or who have taken hormone therapy in
             previous 6 months

          -  Unwilling to give written informed consent

          -  Participation in another study within previous 60 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Collins, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Brompton &amp; Harefield NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2006</study_first_submitted>
  <study_first_submitted_qc>February 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2006</study_first_posted>
  <last_update_submitted>October 21, 2015</last_update_submitted>
  <last_update_submitted_qc>October 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2015</last_update_posted>
  <keyword>arteries</keyword>
  <keyword>blood flow</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genistein</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

